HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: A further obstacle to eradication

Journal of Leukocyte Biology

Volumn 68, Issue 3, 2000, Pages 345-350

  Crowe, S M ^a   Sonza, S ^a  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

Lymphocytes; Macrophages; Persistence; Reservoirs

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 2; VIRUS DNA; VIRUS RNA;

DRUG PENETRATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; MONOCYTES;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033635471     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Analysis of the second phase of viral load decline after HAART-macrophage clearance versus decline in antigen driven immune response
2. HIV-1 dynamics in vivo; virion clearance rate, infected cell life-span, and viral generation time
3. Decay characteristics of HIV-1-infected compartments during combination therapy
4. HIV-1 and HAART: A time to cure, a time to kill
5. Cerebrospinal fluid-HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection; support for the hypothesis of local virus replication
6. Analysis of HIV-1 load in blood, semen and saliva; evidence for different viral compartments in a cross sectional and longitudinal study
7. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions; evidence for viral compartmentalization and selection during sexual transmission
8. Pathogenesis of infection with human immunodeficiency virus
9. Infection of the retina by human immunodeficiency virus type 1
10. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
11. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia
12. HLA-DR positive dendritic cells of the normal human choroid plexus; a potential reservoir of HIV in the central nervous system
13. HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in cerebrospinal fluid
14. Identification of a reservoir of HIV-1 in patients on highly active antiretroviral therapy
15. Recovery of replication competent HIV despite prolonged suppression of plasma viremia
16. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
17. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection
18. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
19. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
20. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged antiretroviral therapy
21. Quantification of HIV-1 viral load in lymphoid and blood cells, assessment during four drug combination therapy
22. Quantification of integrated and total HIV-1 DNA after long term highly active antiretroviral therapy in HIV-1 infected patients
23. Slow, persistent replication of lentiviruses; role of tissue macrophages and macrophage precursors in bone marrow
24. Mononuclear phagocytes as targets, tissue reservoirs and immunoregulatory cells in human immuno-deficiency virus disease
25. HIV-1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes
26. Quantitative immunofluorescent cytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages
27. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1 infected individuals
28. Detection of HIV-1 in human lung macrophages using the polymerase chain reaction
29. Human Kupffer cells infected with HIV-1 in vivo
30. + patients
31. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
32. Macrophages as a source of HIV during opportunistic infections
33. Mononuclear phagocytes of blood and bone marrow; comparative roles as viral reservoirs in human immunodeficiency virus type-1 infections
34. Immunocytochemical quantitation of human immunodeficiency virus in the brain, correlations with dementia
35. Infection of gastrointestinal tract macrophages by HIV-1
36. Direct evidence for a bone marrow origin of the alveolar macrophages in man
37. HIV-1 in monocyte-macrophages of patients receiving potent therapy
38. Bone marrow derived elements and resident microglia in brain inflammation
39. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines infected with the human immunodeficiency virus
40. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus
41. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes
42. HIV infection in macrophage: Role of long-lived cells and related therapeutical strategies
43. Residual HIV-1 disease in the era of highly active antiretroviral therapy
44. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir
45. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex
46. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor
47. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity
48. In vitro blood brain barrier permeability of nevirapine compared to other HIV antiretroviral agents
49. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
50. + T cells using a combination of cytokines
51. Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia
52. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy
53. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy
54. Persistence of episomal HIV-1 infection intermediates in patients on highly active antiretroviral therapy
55. HIV-1 replication in patients with undetectable plasma virus receiving HAART
56. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy
57. Latent reservoirs of HIV: Obstacles to the eradication of virus
58. Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages